Replies to post #9617 on Lexington Biosciences Inc. (LXGTF)

[MikeyLikesStocks]

Since they're on the FDA fast track, I'm thinking at least several months. I know for drug studies on the fast track, the average length until approval is shortened from 10 to 6 months; but this isn't a drug. Side effects? None. So they only have to re-prove its effectiveness in a clinical setting..